한빛사1,412건

• • 문상준(서울대학교)

  • 정문교(서울대학교, 현 삼성바이오로직스)

  • 김병수(서울대학교)

  Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment

  • Adv. Mater. Sep 10 2024, | https://doi.org/10.1002/adma.202410340

  • 2024.09
  • 바이오·의료융합

• • 전희진(울산과학기술원)

  • 여미래(울산과학기술원)

  • 전준표(울산과학기술원)

  • 박성호(울산과학기술원)

  • 김은희(울산과학기술원)

  • 강세병(울산과학기술원)

  CD13-targeting and TRAIL-displaying protein nanoparticles effectively induce apoptotic cell death of acute myeloid leukemia, prolonging survival in mo

  • Nano Today Available online 4 September 2024 | https://doi.org/10.1016/j.nantod.2024.102474

  • 2024.09
  • 생명과학

• • 백승민(기초과학연구원, 서울대학교)

  • 김현민(고려대학교 의과대학)

  • 이윤정(서울대학교, 기초과학연구원)

  • 소민(서울대학교, 현텍엔바이오)

  • 현택환(서울대학교)

  • 김치경(고려대학교 구로병원)

  Orally Deliverable Iron-Ceria Nanotablets for Treatment of Inflammatory Bowel Disease

  • Adv. Healthc. Mater. Sep 05 2024, | https://doi.org/10.1002/adhm.202401994

  • 2024.09
  • 바이오·의료융합

• • Hy Dinh Nguyen(아주대학교)

    Interview

  • 이범진(아주대학교)

  Novel pH-Responsive Structural Rearrangement of Myristic Acid-Conjugated Quetiapine Nanosuspension for Enhanced Long-Acting Delivery Performance

  • Adv. Sci. Sep 03 2024, | https://doi.org/10.1002/advs.202405200

  • 2024.09
  • 의약학

• • 응우엔(성균관대학교)

  • 윤유석(성균관대학교)

  STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy

  • Bioact. Mater. Available online 6 September 2024; 42,345?365 | https://doi.org/10.1016/j.bioactmat.2024.09.002

  • 2024.09
  • 바이오·의료융합
• 

  Hy Dinh Nguyen

  아주대학교

  Quetiapine (QTP) is a first-line antipsychotic drug for the treatment of schizophrenia; however, lifelong daily administration of QTP tablets is associated with a low patient acceptance profile. Accordingly, substituting oral dosage forms with long-acting injectables can potentially improve patient compliance and treatment effectiveness.

  • Adv. Sci.
  • 2024.09.11

• • 정예희(이화여자대학교 약학대학)

  • 신수민(이화여자대학교)

  • 서원효(이화여자대학교)

  • 이혁진(이화여자대학교 약학대학)

  Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis

  • J. Control. Release Aug 22 2024, 374 S0168-3659(24)00551-0 | https://doi.org/10.1016/j.jconrel.2024.08.012

  • 2024.08
  • 의약학

• • 곽기정(University of Maryland)

  • 석정수(University of Maryland, Johns Hopkins University School of Medicine)

  Brain Nucleic Acid Delivery and Genome Editing via Focused Ultrasound-Mediated Blood-Brain Barrier Opening and Long-Circulating Nanoparticles

  • ACS Nano Aug 22 2024, | https://doi.org/10.1021/acsnano.4c05270

  • 2024.08
  • 바이오·의료융합

• • Duy-Thuc Nguyen(서울대학교 약학대학)

  • 백민준(서울대학교 약학대학 (현 Massachusetts General Hospital and Harvard Medical School))

  • 이재영(서울대학교 약학대학)

  • 김대덕(서울대학교)

  Photobleaching-mediated charge-convertible cyclodextrin nanoparticles achieve deep tumour penetration for rectal cancer theranostics

  • Nat. Nanotechnol. 21 August 2024 | https://doi.org/10.1038/s41565-024-01757-4

  • 2024.08
  • 바이오·의료융합

• • 이동근(동아대학교)

  • 김규리(동아대학교)

  • 조완섭(동아대학교)

  Multimodal pulmonary clearance kinetics of carbon black nanoparticles deposited in the lungs of rats: the role of alveolar macrophages

  • Part. Fibre Toxicol. Aug 12 2024, 21 (1) | https://doi.org/10.1186/s12989-024-00591-9

  • 2024.08
  • 의약학

• • 한승연(서울시립대학교)

  • 최인희(서울시립대학교)

  Label-free and liquid state SERS detection of multi-scaled bioanalytes via light-induced pinpoint colloidal assembly

  • Biosens. Bioelectron. Aug 12 2024, 264 S0956-5663(24)00669-9 | https://doi.org/10.1016/j.bios.2024.116663

  • 2024.08
  • 바이오·의료융합

• • 류지연(Harvard Medical School, Brigham and Women’s Hospital)

  • 류일환(국민대학교)

  Brain-targeted intranasal delivery of protein-based gene therapy for treatment of ischemic stroke

  • Theranostics 2024.08.12 ;14(12):4773-4786 | https://www.thno.org/v14p4773

  • 2024.08
  • 바이오·의료융합

• • Fakhar Ud Din(한양대학교 약학대학)

  • 김정석(한양대학교 약학대학)

  • 최한곤(한양대학교 약학대학)

  Injectable dual thermoreversible hydrogel for sustained intramuscular drug delivery

  • J. Control. Release Aug 30 2024, 374 S0168-3659(24)00584-4 | https://doi.org/10.1016/j.jconrel.2024.08.034

  • 2024.08

• • 장윤수(부산대학교)

  • 이은희(부산대학교)

  Interference-resistant gold nanoparticle assay for detecting Enterococcus in fresh and marine waters

  • J. Hazard. Mater. Aug 09 2024, 478 S0304-3894(24)02042-9 | https://doi.org/10.1016/j.jhazmat.2024.135463

  • 2024.08

• • 장민철(KAIST)

  • 박지호(KAIST)

  Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration

  • ACS Nano Aug 22 2024, | https://doi.org/10.1021/acsnano.4c05653

  • 2024.08
  • 바이오·의료융합

• • 최원민(Harvard Medical School)

  Hybrid Nanoparticle-Hydrogel Systems for Drug Delivery Depots and Other Biomedical Applications

  • ACS Nano Aug 14 2024, | https://doi.org/10.1021/acsnano.4c06888

  • 2024.08
  • 바이오·의료융합

• • 한정필(서울대학교)

  • 남유리(KAIST)

  • 이해신(KAIST)

  • 염수청(서울대학교)

  Polyphenol-Enabled 2D Nanopatch for Enhanced Nasal Mucoadhesion and Immune Activation

  • Nano Lett. Aug 09 2024, | https://doi.org/10.1021/acs.nanolett.4c03228

  • 2024.08
  • 바이오·의료융합

• • 이종원(한국과학기술연구원(KIST))

  • 양유수(한국과학기술연구원(KIST))

  • 김선화(한국과학기술연구원(KIST))

  Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy

  • ACS Nano Aug 08 2024, | https://doi.org/10.1021/acsnano.4c06471

  • 2024.08
  • 바이오·의료융합

• • 이재현(건국대학교)

    Interview

  • 임한솔(건국대학교)

    Interview

  • 권세호(전남대학교)

  • 박주호(건국대학교)

  Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect

  • Nat. Commun. 08 August 2024 | https://doi.org/10.1038/s41467-024-50819-7

  • 2024.08
  • 의약학

• • 김경란(한국과학기술연구원)

  • 강지희(가천대학교 약학대학)

  • 고영탁(가천대학교 약학대학)

  • 안대로(한국과학기술연구원, UST)

  Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona-Assisted DNA Cubes

  • Small Methods Aug 02 2024, | https://doi.org/10.1002/smtd.202400902

  • 2024.08
  • 의약학